Cargando…

Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology

Background: Intraocular lymphoma (IOL) presents a real challenge in daily diagnostics. Cyto- and/or histopathology of vitreous body represent the diagnostic cornerstones. Yet, false negative results remain common. Therefore, we analyzed the diagnostic significance of flow cytometry (FC) within the w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shumilov, Evgenii, Mazzeo, Paolo, Zinkernagel, Martin S., Legros, Myriam, Porret, Naomi, Romagna, Lorenz, Haase, Detlef, Lenz, Georg, Novak, Urban, Banz, Yara, Pabst, Thomas, Bacher, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870741/ https://www.ncbi.nlm.nih.gov/pubmed/35200564 http://dx.doi.org/10.3390/curroncol29020065

Ejemplares similares

Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients
por: Nydegger, Anna, et al.
Publicado: (2021)

Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series
por: Flach, Johanna, et al.
Publicado: (2020)

CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement
por: Shumilov, Evgenii, et al.
Publicado: (2023)

Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias
por: Rebmann Chigrinova, Ekaterina, et al.
Publicado: (2022)

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
por: Bacher, Ulrike, et al.
Publicado: (2018)

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy
por: Rentsch, Vera, et al.
Publicado: (2022)

BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study
por: Stoffel, Tanja, et al.
Publicado: (2022)

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma
por: Heini, Alexander D., et al.
Publicado: (2022)

Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment
por: von Matt, Stefanie, et al.
Publicado: (2023)

CAR T-cell therapy and critical care: A survival guide for medical emergency teams
por: Messmer, Anna S., et al.
Publicado: (2021)

Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland
por: Messmer, Anna Sarah, et al.
Publicado: (2021)

Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma
por: Huwyler, Fabrizio, et al.
Publicado: (2023)

Systemic mastocytosis with an associated hematological neoplasms: One or two entities?
por: Njue, Linet, et al.
Publicado: (2020)

Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients
por: Schnell, Bianca R., et al.
Publicado: (2019)

Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients
por: Shumilov, Evgenyi, et al.
Publicado: (2019)

Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma
por: Messerli, Christian, et al.
Publicado: (2023)

Blinatumomab in Relapsed/Refractory Burkitt Lymphoma
por: Bohler, Jeanne, et al.
Publicado: (2022)

Flow cytometry, molecular analysis, and other special techniques (in Serous Fluid Cytopathology)
por: Gabali, Ali
Publicado: (2022)

Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation—A Phase I Study
por: Rausch, Christian, et al.
Publicado: (2022)

Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
por: Shumilov, Evgenii, et al.
Publicado: (2021)

An unusual pseudolymphoma in the context of necrotizing fasciitis: A case report
por: Dislich, Bastian, et al.
Publicado: (2022)

Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML
por: Heini, Alexander D., et al.
Publicado: (2021)

sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
por: Seipel, Katja, et al.
Publicado: (2022)

Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma
por: Bühler, Selina, et al.
Publicado: (2023)

Cancer cytopathology.
Publicado: (1997)

Comprehensive cytopathology /
Publicado: (1991)

GYNECOLOGIC CYTOPATHOLOGY
Publicado: (1979)

Digital cytopathology
por: Nishat, Roquaiya, et al.
Publicado: (2017)

Patient-specific workup of adrenal incidentalomas
por: Haan, Romy R. de, et al.
Publicado: (2017)

P1302: INTEGRATION OF ROUTINE RNA AND WHOLE-EXOME SEQUENCING AND FLOW CYTOMETRY IMPROVES THE DIAGNOSTIC WORKUP OF PEDIATRIC LYMPHOMAS
por: Westera, L., et al.
Publicado: (2022)

Atlas of diagnostic cytopathology
Publicado: (2004)

Practical urologic cytopathology /
por: Bardales, Ricardo H.
Publicado: (2002)

Atlas of diagnostic cytopathology
Publicado: (1992)

Digital Imaging in Cytopathology
por: Khalbuss, Walid E., et al.
Publicado: (2011)

The Cytopathology of Virus Infection
por: Black, Francis L.
Publicado: (1960)

Contaminants and Mimickers in Cytopathology
por: Muzarath, S, et al.
Publicado: (2020)

Aspiration Cytopathology of Peripancreatic Space: A Clinicoradiologic and Cytopathologic Analyses of 42 Cases
por: Bishop, Justin, et al.
Publicado: (2013)

Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice
por: Hong, Soon Auck, et al.
Publicado: (2022)

Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients
por: Sanoyan, Dilara Akhoundova, et al.
Publicado: (2023)

Commentary: Pre-aesthetic workup: Should it be a part of pre-refractive surgery workup?
por: Sachdev, Ritika
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ijjj6u111kinurgfffjadpcb6l